G(i1) and G(oA) differentially determine kinetic efficacies of agonists for κ-opioid receptor

FEBS Letters

Volumn 473, Issue 1, 2000, Pages 101-105

  Kohno, Masayuki ^a   Fukushima, Nobuyuki ^a   Yoshida, Akira ^a   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Opioid receptor; G protein; Reconstitution

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DYNORPHIN A; DYNORPHIN B; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE; PROTEIN SUBUNIT; SULFUR 35; TRITIUM;

ANIMAL CELL; ARTICLE; BACULOVIRUS; BINDING AFFINITY; BINDING COMPETITION; BINDING KINETICS; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENETIC TRANSFECTION; MEMBRANE RECONSTITUTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BENZENEACETAMIDES; BINDING, COMPETITIVE; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; ENZYME ACTIVATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; HETEROTRIMERIC GTP-BINDING PROTEINS; KINETICS; LIGANDS; MAGNESIUM; NARCOTIC ANTAGONISTS; PROTEIN BINDING; PYRROLIDINES; RATS; RECEPTORS, OPIOID, KAPPA; SPODOPTERA; THERMODYNAMICS; TRANSDUCTION, GENETIC;

UNIDENTIFIED BACULOVIRUS;

EID: 0034604149     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01495-2     Document Type: Article

References (21)

1. Gilman A.G. Annu. Rev. Biochem. 56:1987;615-649.
2. Ueda H., Nozaki M., Satoh M. Comp. Biochem. Physiol. 98c:1991;157-169.
3. Milligan G., MacEwan D.J., Mercouris M., Mullancy I. Receptors Channels. 5:1997;209-213.
4. Koch T., Schulz S., Schroeder H., Wolf R., Raulf E., Hollt V. J. Biol. Chem. 273:1998;13652-13657.
5. Ueda H., Harada H., Nozaki M., Katada T., Ui M., Satoh M., Takagi H. Proc. Natl. Acad. Sci. USA. 85:1988;7013-7017.
6. Ueda H., Miyamae T., Hayashi C., Watanabe S., Fukushima N., Sasaki Y., Iwamura T., Misu Y. J. Neurosci. 15:1995;7485-7499.
7. Ueda H., Miyamae T., Fukushima N., Takeshima H., Fukuda K., Sasaki Y., Misu Y. Mol. Brain Res. 32:1995;166-170.
8. Corbett, A.D., Paterson, S.J. and Kosterlitz, H.W. (1993) in: Handbook of Experimental Pharmacology: Opioids I (Herz, A., Ed.), pp. 645-679, Springer-Verlag, Berlin.
9. Zadina J.E., Hackler L., Ge L.J., Kastin A.J. Nature. 386:1997;499-502.
10. Law P.Y., Loh H.H. J. Pharmacol. Exp. Ther. 289:1999;607-624.
11. Hattori S., Okuda K., Hamajima K., Sakimura K., Mishina M., Kawamoto S. Brain Res. 666:1994;43-52.
12. Vialard J., Lalumiere M., Vernet T., Briedis D., Alkhatib G., Henning D., Levin D., Richardson C. J. Virol. 64:1990;37-50.
13. Groebe D.R., Chung A.E., Ho C. Nucleic Acids Res. 18:1990;4033.
14. Kawamoto S., Onishi H., Hattori S., Miyagi Y., Amaya Y., Mishina M., Okuda K. Biochem. Biophys. Res. Commun. 181:1991;756-763.
15. Smith G.E., Summers M.D., Fraser M.J. Mol. Cell. Biol. 3:1983;2156-2165.
16. Nakamura F., Kato M., Kameyama K., Nukada T., Haga T., Kato H., Takenawa T., Kikkawa U. J. Biol. Chem. 270:1995;6246-6253.
17. Fukushima N., Kohno M., Kato T., Kawamoto S., Okuda K., Misu Y., Ueda H. Peptides. 19:1998;811-819.
18. Laemmli U.K. Nature. 227:1970;680-685.
19. Yoshida A., Ueda H. Biochem. Biophys. Res. Commun. 259:1999;78-84.
20. Pang I.-H., Sternweis P.C. J. Biol. Chem. 265:1990;18707-18712.
21. Asano T., Semba R., Ogasawara N., Kato K. J. Neurochem. 48:1987;1617-1623.